You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

623 Results
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pralatrexate - Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PRALAtrexate,
leucovorin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2023
Document
Aug 2018
Blog posts

Blog Category: Our Partners and the System

Passionate. Committed. Patient-focused. These are just a few of the words that have been used to describe this year’s Human Touch Award recipients in...
Sep 2018
Document
Sep 2018
Guidelines and Advice
Status: Current
ID: pet 2018-1
Version: n/a
Oct 2018
Document
Nov 2018
Document
Nov 2018
Document
Nov 2018
Document
Nov 2018
Document
Nov 2018
Document
Feb 2019
Document
Feb 2019

Pages